Neogen Corp. Opens Weak with 6.15% Gap Down Amid Market Concerns

Neogen Corp., a small-cap player in the Pharmaceuticals & Biotechnology sector, opened today with a significant loss of 6.15%. This decline is part of a broader trend, as the stock has experienced a 9.82% drop over the past day, contrasting sharply with the S&P 500's performance, which fell by only 1.51%. Over the past month, Neogen Corp. has seen a substantial decrease of 25.02%, while the S&P 500 has declined by 5.83%. In terms of technical indicators, the weekly MACD suggests a mildly bearish outlook, while the monthly MACD indicates a mildly bullish trend. The Bollinger Bands reflect a bearish sentiment on both weekly and monthly scales. Moving averages show a mildly bullish trend on a daily basis, but the overall technical picture remains mixed. Neogen Corp. has a market capitalization of approximately USD 1,982 million, with a price-to-earnings ratio of 150.00. The company currently does not offer a dividend, and its debt-to-equity ratio stands at 0.31, with a return on equity of 0.63% and a price-to-book ratio of 0.94.